annual CFI:
-$280.48M-$655.13M(-174.87%)Summary
- As of today (June 28, 2025), CRSP annual cash flow from investing activities is -$280.48 million, with the most recent change of -$655.13 million (-174.87%) on December 31, 2024.
- During the last 3 years, CRSP annual CFI has risen by +$754.95 million (+72.91%).
- CRSP annual CFI is now -174.87% below its all-time high of $374.65 million, reached on December 31, 2023.
Performance
CRSP Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$19.75M-$125.58M(-118.67%)Summary
- As of today (June 28, 2025), CRSP quarterly cash flow from investing activities is -$19.75 million, with the most recent change of -$125.58 million (-118.67%) on March 31, 2025.
- Over the past year, CRSP quarterly CFI has increased by +$78.05 million (+79.80%).
- CRSP quarterly CFI is now -109.11% below its all-time high of $216.92 million, reached on June 30, 2023.
Performance
CRSP quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$202.44M+$78.05M(+27.83%)Summary
- As of today (June 28, 2025), CRSP TTM cash flow from investing activities is -$202.44 million, with the most recent change of +$78.05 million (+27.83%) on March 31, 2025.
- Over the past year, CRSP TTM CFI has dropped by -$361.45 million (-227.30%).
- CRSP TTM CFI is now -154.03% below its all-time high of $374.65 million, reached on December 31, 2023.
Performance
CRSP TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
CRSP Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -174.9% | +79.8% | -227.3% |
| 3 y3 years | +72.9% | +82.8% | +79.4% |
| 5 y5 years | -10000.0% | -560.5% | -10000.0% |
CRSP Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -174.9% | +72.9% | -109.1% | +88.8% | -154.0% | +79.4% |
| 5 y | 5-year | -174.9% | +72.9% | -109.1% | +96.5% | -154.0% | +83.5% |
| alltime | all time | -174.9% | +72.9% | -109.1% | +96.5% | -154.0% | +83.5% |
CRSP Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$19.75M(-118.7%) | -$202.44M(-27.8%) |
| Dec 2024 | -$280.48M(-174.9%) | $105.83M(-165.5%) | -$280.48M(-40.0%) |
| Sep 2024 | - | -$161.60M(+27.3%) | -$467.76M(+153.1%) |
| Jun 2024 | - | -$126.91M(+29.8%) | -$184.81M(-216.2%) |
| Mar 2024 | - | -$97.80M(+20.1%) | $159.02M(-57.6%) |
| Dec 2023 | $374.65M(-244.8%) | -$81.45M(-167.1%) | $374.65M(+33.5%) |
| Sep 2023 | - | $121.35M(-44.1%) | $280.57M(+13.7%) |
| Jun 2023 | - | $216.92M(+84.1%) | $246.68M(-1037.6%) |
| Mar 2023 | - | $117.83M(-167.1%) | -$26.31M(-89.8%) |
| Dec 2022 | -$258.65M(-75.0%) | -$175.53M(-300.7%) | -$258.65M(+181.6%) |
| Sep 2022 | - | $87.46M(-256.0%) | -$91.84M(-87.7%) |
| Jun 2022 | - | -$56.07M(-51.0%) | -$744.48M(-24.2%) |
| Mar 2022 | - | -$114.52M(+1213.8%) | -$982.05M(-5.2%) |
| Dec 2021 | -$1.04B(+91.3%) | -$8.72M(-98.5%) | -$1.04B(-15.9%) |
| Sep 2021 | - | -$565.18M(+92.5%) | -$1.23B(+23.6%) |
| Jun 2021 | - | -$293.64M(+74.9%) | -$996.11M(+41.1%) |
| Mar 2021 | - | -$167.90M(-17.8%) | -$706.08M(+30.5%) |
| Dec 2020 | -$541.17M | -$204.24M(-38.2%) | -$541.17M(+64.1%) |
| Sep 2020 | - | -$330.33M(+9063.1%) | -$329.87M(>+9900.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | -$3.60M(+20.5%) | -$2.00M(+251.5%) |
| Mar 2020 | - | -$2.99M(-142.4%) | -$569.00K(-142.9%) |
| Dec 2019 | $1.32M(-147.8%) | $7.06M(-386.8%) | $1.32M(-119.7%) |
| Sep 2019 | - | -$2.46M(+13.2%) | -$6.73M(+35.6%) |
| Jun 2019 | - | -$2.17M(+98.2%) | -$4.97M(+49.8%) |
| Mar 2019 | - | -$1.10M(+9.7%) | -$3.31M(+19.5%) |
| Dec 2018 | -$2.77M(-66.6%) | -$1.00M(+43.9%) | -$2.77M(+40.2%) |
| Sep 2018 | - | -$695.00K(+32.9%) | -$1.98M(-58.6%) |
| Jun 2018 | - | -$523.00K(-5.8%) | -$4.78M(-14.5%) |
| Mar 2018 | - | -$555.00K(+170.7%) | -$5.58M(-32.8%) |
| Dec 2017 | -$8.31M(-126.1%) | -$205.00K(-94.1%) | -$8.31M(-224.8%) |
| Sep 2017 | - | -$3.49M(+162.7%) | $6.66M(-23.0%) |
| Jun 2017 | - | -$1.33M(-59.5%) | $8.65M(-3.2%) |
| Mar 2017 | - | -$3.29M(-122.2%) | $8.93M(-72.0%) |
| Dec 2016 | $31.88M(-2862.9%) | $14.77M(-1078.9%) | $31.88M(+86.3%) |
| Sep 2016 | - | -$1.51M(+44.1%) | $17.11M(-8.1%) |
| Jun 2016 | - | -$1.05M(-105.3%) | $18.62M(-5.3%) |
| Mar 2016 | - | $19.67M | $19.67M |
| Dec 2015 | -$1.15M(<-9900.0%) | - | - |
| Dec 2014 | $0.00 | - | - |
FAQ
- What is CRISPR Therapeutics AG annual cash flow from investing activities?
- What is the all time high annual CFI for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual CFI year-on-year change?
- What is CRISPR Therapeutics AG quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly CFI year-on-year change?
- What is CRISPR Therapeutics AG TTM cash flow from investing activities?
- What is the all time high TTM CFI for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG TTM CFI year-on-year change?
What is CRISPR Therapeutics AG annual cash flow from investing activities?
The current annual CFI of CRSP is -$280.48M
What is the all time high annual CFI for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual cash flow from investing activities is $374.65M
What is CRISPR Therapeutics AG annual CFI year-on-year change?
Over the past year, CRSP annual cash flow from investing activities has changed by -$655.13M (-174.87%)
What is CRISPR Therapeutics AG quarterly cash flow from investing activities?
The current quarterly CFI of CRSP is -$19.75M
What is the all time high quarterly CFI for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly cash flow from investing activities is $216.92M
What is CRISPR Therapeutics AG quarterly CFI year-on-year change?
Over the past year, CRSP quarterly cash flow from investing activities has changed by +$78.05M (+79.80%)
What is CRISPR Therapeutics AG TTM cash flow from investing activities?
The current TTM CFI of CRSP is -$202.44M
What is the all time high TTM CFI for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high TTM cash flow from investing activities is $374.65M
What is CRISPR Therapeutics AG TTM CFI year-on-year change?
Over the past year, CRSP TTM cash flow from investing activities has changed by -$361.45M (-227.30%)